IsoRay ships first GliaSite system; CARMAT gets OK in France for trial with artificial heart;

> IsoRay has shipped its first GliaSite radiation therapy system. The GliaSite radiation therapy system is a balloon catheter device used in the treatment of brain cancer. IsoRay release

> CARMAT has been given the go‐ahead from the Patient Protection Committee for the first clinical trial in France involving the implantation of the total artificial heart in patients. CARMAT release

> GE Healthcare ($GE) announced an additional $300 million investment in low-dose technologies and unveiled radiation-dose management offerings at RSNA 2011. GE release

> Randox Food Diagnostics' Anthelmintics testing platform (EV3770) has been released. This multi-analyte testing array is used in conjunction with the patented Randox Biochip Array Technology and Evidence Investigator analyzer. The extensive test menu includes Avermectins, Benzimidazoles, Amino-benzimidazoles, Levamisole, Thiabendazole, Moxidectin and Triclabendazole. Randox release

> Intelerad Medical Systems has unveiled a new mobile-friendly interface for the InteleConnect web portal--a brandable, browser-based solution for communicating radiology results to referring physicians. Intelerad release

And Finally... Researchers are offering hope to victims of serious facial injuries through the combination of conventional medical imaging and the same 3-D modeling techniques used in Hollywood. Results of a new study on human face transplantation have been presented at the annual meeting of the Radiological Society of North America. RSNA release

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.